Director Jason Raleigh Nunn purchases 63,158 shares of ZBIO at $19.00 ($1.2M); stock now $25.85; 5 insiders bought in past 14 days
Jason Raleigh Nunn, a Director, purchased 63,158 shares at $19.00 on 2025-10-09, increasing his holdings to 1,173,395 shares (a 5.7% increase). The stock has appreciated to $25.85, representing a +27.8% gain over the prior 30 days and a +97.8% gain over the prior 90 days. However, this positive near-term price action must be contextualized against both the insider's track record and the company's fundamentals. His prior 2 open-market buys across all tickers averaged a 90-day return of -47.5%, with a 0.00% win rate at the 90-day mark; his same-ticker history at ZBIO (2 prior buys on 2024-09-16) shows identical 90-day results of -47.5%. Additionally, the company is unprofitable (net income of -$52,223,000.00), reported zero revenue in its latest quarter, and experienced -90.0% annual revenue decline year-over-year, creating a significant fundamental headwind despite the recent stock momentum. A cluster of 5 other insiders also buying within the past 14 days suggests coordinated interest, though this does not alter the underlying operational challenges evident in the financials.